New drug mimics IVIg to tame nerve inflammation
NCT ID NCT07027111
First seen Apr 19, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This study tests a new drug called NVG-2089 in 60 adults with CIDP, a chronic nerve condition that causes weakness and numbness. The drug is designed to calm the immune system, similar to IVIg therapy. Researchers will check if it is safe and if it helps improve symptoms over 14 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nuvig Site
Denton, Texas, 76208, United States
Conditions
Explore the condition pages connected to this study.